{
    "id": 28502,
    "fullName": "NF1 Q642*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "NF1 Q642* results in a premature truncation of the Nf1 protein at amino acid 642 of 2839 (UniProt.org). Due to the loss of all known functional domains (UniProt.org), Q642* is predicted to result in a loss of function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4763,
        "geneSymbol": "NF1",
        "terms": [
            "NF1",
            "NFNS",
            "VRNF",
            "WSS"
        ]
    },
    "variant": "Q642*",
    "createDate": "07/20/2018",
    "updateDate": "07/20/2018",
    "referenceTranscriptCoordinates": {
        "id": 176365,
        "transcript": "NM_001042492",
        "gDna": "chr17:g.31225173C>T",
        "cDna": "c.1924C>T",
        "protein": "p.Q642*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14603,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a non-small cell lung carcinoma patient harboring EML4-ALK demonstrated resistance to two individual treatments, Xalkori (crizotinib) and Alecensa (alectinib), and secondary testing demonstrated the patient had acquired NF1 Q642* (PMID: 29636358).",
            "molecularProfile": {
                "id": 30273,
                "profileName": "EML4 - ALK NF1 Q642*"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 11739,
                    "pubMedId": 29636358,
                    "title": "Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636358"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30271,
            "profileName": "NF1 Q642*",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30273,
            "profileName": "EML4 - ALK NF1 Q642*",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 176367,
            "transcript": "XM_005257983",
            "gDna": "chr17:g.31225173C>T",
            "cDna": "c.1924C>T",
            "protein": "p.Q642*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 176368,
            "transcript": "XM_005257984",
            "gDna": "chr17:g.31225173C>T",
            "cDna": "c.1924C>T",
            "protein": "p.Q642*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 176366,
            "transcript": "NM_000267",
            "gDna": "chr17:g.31225173C>T",
            "cDna": "c.1924C>T",
            "protein": "p.Q642*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 176365,
            "transcript": "NM_001042492",
            "gDna": "chr17:g.31225173C>T",
            "cDna": "c.1924C>T",
            "protein": "p.Q642*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}